Description

Valganciclovir Tablets

Healthy Inc is a specialized global supplier and exporter of advanced virology, immunology, and transplant-medicine therapeutics. We provide ultra-high-purity, highly bioavailable Valganciclovir Tablets (450 mg), manufactured in WHO–GMP certified, dedicated negative-pressure hazardous drug containment facilities. This “Advanced Prodrug Antiviral” is a high-value, critical-care export to organ transplant centers, infectious disease wards, HIV/AIDS clinics, and government health ministries in LATAM, the Middle East, Southeast Asia, and Africa, serving as the definitive, life-saving outpatient intervention for Cytomegalovirus (CMV) retinitis and systemic CMV prophylaxis.

Product Overview

This formulation contains Valganciclovir (as Valganciclovir Hydrochloride), an L-valyl ester prodrug of ganciclovir. It is a masterpiece of pharmaceutical engineering designed to overcome the severe absorption limitations of older antivirals.

The “Outpatient Transplant Defense” Specialist:

• Mechanism 1 (The Esterase Cleavage): Oral ganciclovir has notoriously poor bioavailability (around 5-9%). Valganciclovir solves this by attaching an amino acid (valine) to the molecule, which tricks the intestines into absorbing it rapidly via peptide transporters. Once inside the intestinal wall and liver, cellular esterases instantly cleave the valine off, flooding the bloodstream with massive, IV-equivalent levels of active ganciclovir.
• Mechanism 2 (Viral DNA Termination): Once the active ganciclovir reaches the CMV-infected cells, it is phosphorylated by viral and human kinases. It then physically impersonates a DNA building block, jamming the viral DNA polymerase enzyme and completely terminating the replication of the virus.
• The Outpatient Revolution: Because a single 900 mg oral dose of Valganciclovir provides the exact same daily blood exposure (AUC) as a 5 mg/kg intravenous infusion of ganciclovir, patients can be discharged from the hospital much sooner. This drastically reduces the cost of care for hospital networks and drastically improves the quality of life for solid organ transplant recipients.

Product Composition & Strength

We supply this product as a Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles for chronic dispensing regimens.

*Pack Sizes: HDPE Bottles of 60 tablets / Alu-Alu Blisters (Optimized for strict, high-volume daily adherence regimens in post-operative transplant patients).

Technical & Logistics Specifications

Critical data for Pharmaceutical Importers, Infectious Disease NGOs, and Transplant Networks.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

• Hazardous Drug (OEB) Containment: Valganciclovir is classified as a hazardous, cytotoxic drug due to its severe mutagenic and teratogenic properties. Our manufacturing is executed within strictly isolated, completely dedicated blocks operating under severe negative pressure with multi-stage HEPA filtration. Powders are handled inside closed-loop barrier isolators to guarantee absolute operator safety and zero cross-contamination.
• Prodrug Stability Engineering: Because the valine ester bond can be vulnerable to premature hydrolysis if exposed to moisture during manufacturing, our facilities utilize advanced dry granulation and strict dehumidification protocols to ensure the prodrug remains 100% intact until it reaches the patient’s digestive tract.

Therapeutic Indications (Human Use)

Indicated for the comprehensive management of severe viral infections in immunocompromised populations:

• CMV Retinitis: Treatment of Cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS).
• CMV Disease Prophylaxis: Prevention of CMV disease in high-risk solid organ transplant patients (kidney, heart, and kidney-pancreas). Note: It is not indicated for use in liver transplant patients due to clinical trial outcomes.

Dosage & Administration

Recommended Dosage (Strictly as per Transplant or Infectious Disease Specialist):

• Administration (FOOD REQUIREMENT IS CRITICAL): Valganciclovir MUST be taken with food. Taking it with a meal massively increases its systemic bioavailability, which is absolutely essential for achieving therapeutic antiviral blood levels and preventing fatal viral resistance.
• Handling Precautions (HAZARD WARNING): Tablets MUST be swallowed whole. They MUST NOT be broken or crushed. Valganciclovir is considered a potential human carcinogen and teratogen. Avoid direct contact with broken or crushed tablets. If contact occurs, wash thoroughly with soap and water.
• Renal Adjustment: Because the active metabolite is excreted almost entirely by the kidneys, the dose must be heavily adjusted (reduced) in patients with renal impairment to prevent fatal bone marrow toxicity.

Safety Warnings (CRITICAL):

• BLACK BOX WARNING (Hematologic Toxicity): Valganciclovir causes severe, life-threatening myelosuppression. It frequently induces profound severe leukopenia, neutropenia, anemia, thrombocytopenia, and pancytopenia. Complete blood counts (CBC) must be monitored continuously. The drug must not be initiated if the absolute neutrophil count is less than 500 cells/μL, or the platelet count is less than 25,000 cells/μL.
• BLACK BOX WARNING (Teratogenicity & Mutagenicity): Animal studies demonstrate that Valganciclovir causes catastrophic birth defects and fetal death. It also causes temporary or permanent inhibition of spermatogenesis in males. It is strictly contraindicated in pregnancy. Females and males of reproductive potential must use highly effective contraception during therapy and for at least 90 days following the final dose.
• BLACK BOX WARNING (Carcinogenicity): Valganciclovir has been shown to be carcinogenic in animal models. It should be handled and prescribed with the exact same caution as chemotherapy drugs.

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving the needs of international Pharma Traders, Wholesalers, and Bulk Drug Distributors. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Antiviral and Transplant Formulations, allowing brands to launch high-quality generic medicines under their own label. Whether you are looking for a reliable NGO Tender Supplier for HIV/AIDS programs in Africa or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures timely delivery. We actively support Pharmaceutical Drop Shipping models and bulk indenting, ensuring that every Specialty Medicine Wholesaler receives WHO-GMP certified products at competitive rates.